Vol 92, No 1 (2021)
Clinical vignette
Published online: 2020-12-15
Long-term response to hormone therapy in a young woman with aggressive pelvic angiomyxoma
Abstract
Not available
Keywords: aggressive angiomyxomaantiestrogen therapypelvic tumor
References
- Chen H, Zhao H, Xie Y, et al. Clinicopathological features and differential diagnosis of aggressive angiomyxoma of the female pelvis: 5 case reports and literature review. Medicine (Baltimore). 2017; 96(20): e6820.
- Sun Y, Zhu L, Chang X, et al. Clinicopathological Features and Treatment Analysis of Rare Aggressive Angiomyxoma of the Female Pelvis and Perineum - a Retrospective Study. Pathol Oncol Res. 2017; 23(1): 131–137.
- Haldar K, Martinek IE, Kehoe S. Aggressive angiomyxoma: a case series and literature review. Eur J Surg Oncol. 2010; 36(4): 335–339.
- Schwartz PE, Hui P, McCarthy S. Hormonal therapy for aggressive angiomyxoma: a case report and proposed management algorithm. J Low Genit Tract Dis. 2014; 18(2): E55–E61.
- Hajjar R, Alharthi M, Richard C, et al. Pelvic Aggressive Angiomyxoma: Major Challenges in Diagnosis and Treatment. Cureus. 2019; 11(4): e4419.
- Aguilar-Frasco J, Ruben-Castillo C, Rodríguez-Quintero JH, et al. Aggressive angiomyxoma: giant recurrence successfully treated with wide excision and adjuvant therapy with GnRH analogue. BMJ Case Rep. 2018; 11(1).
- Alobaid A, Goffin F, Lussier C, et al. Aggressive Angiomyxoma of the Vulva or Perineum: Report of Three Patients. J Obstet Gynaecol Can. 2005; 27(11): 1023–1026.
- Aye C, Jefferis H, Chung DY, et al. A case of multi-modal managed vulval aggressive angiomyxoma diagnosed before conception and monitored during pregnancy. Gynecol Oncol. 2009; 115(1): 170–171.
- Bai HM, Yang JX, Huang HF, et al. Individualized managing strategies of aggressive angiomyxoma of female genital tract and pelvis. Eur J Surg Oncol. 2013; 39(10): 1101–1108.
- Fine BA, Munoz AK, Litz CE, et al. Primary medical management of recurrent aggressive angiomyxoma of the vulva with a gonadotropin-releasing hormone agonist. Gynecol Oncol. 2001; 81(1): 120–122.
- Fucà G, Hindi N, Ray-Coquard I, et al. Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study. Oncologist. 2019; 24(7): e536–e541.
- Im SW, Han SSu. Treatment of aggressive angiomyxoma of the female perineum: Combined operative and hormone therapy. J Obstet Gynaecol. 2016; 36(6): 819–821.
- McCluggage WG, Jamieson T, Dobbs SP, et al. Aggressive angiomyxoma of the vulva: Dramatic response to gonadotropin-releasing hormone agonist therapy. Gynecol Oncol. 2006; 100(3): 623–625.
- Palomba S, Oppedisano R, Annunziata G, et al. Leuprolide acetate depot plus high-dose raloxifene hydrochloride before and after surgery for recurrent vaginal aggressive angiomyxoma: a case report. Gynecol Oncol. 2011; 123(1): 172–173.
- Abu JI, Bamford WM, Malin G, et al. Aggressive angiomyxoma of the perineum. Int J Gynecol Cancer. 2005; 15(6): 1097–1100.
- Magtibay PM, Salmon Z, Keeney GL, et al. Aggressive angiomyxoma of the female pelvis and perineum: a case series. Int J Gynecol Cancer. 2006; 16(1): 396–401.
- Giles DL, Liu PT, Lidner TK, et al. Treatment of aggressive angiomyxoma with aromatase inhibitor prior to surgical resection. Int J Gynecol Cancer. 2008; 18(2): 375–379.
